American Bio Medica Corp (ABMC)

[The Rainbow]

Forward thinking; testing requirements, while vaccines are introduced and the heightened vigilance of the government as these new vaccines are monitored, should be high. So $ABMC should do better quarter over quarter into summer/fall 2021.

Being a test distributor vs strictly a manufacturer allows the company to represent the most current and demanded products. As an example,demand will increase for the saliva ABC rapid test which also diagnoses the flu virus as will as C-19. On the PCR side the CODX test is showing top of the line results. Management is also clear that several new opportunities are being worked on.

All types of tests are still in short supply and winter is just beginning. Pressure to test will increase.

After a period of time with the vaccine (which has a limited functional time in the body) in general use, I could see an at home based test, such a today's pregnancy test, being in demand.

The question is- (drum roll) will management work to increase share price to maximize value for funding, investment opportunities, and future cash, thus increasing shareholder value before these opportunities dry up?